VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SRPT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SRPTSarepta Therapeutics, Inc.
$19.18$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSRPTQuarterly Financials

Sarepta Therapeutics, Inc. (SRPT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Sarepta Therapeutics, Inc. (SRPT) quarterly income statement — complete revenue, gross profit & net income history

SRPT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue730.8M442.93M399.36M611.09M744.86M658.41M467.17M362.93M413.46M396.78M331.82M261.24M253.5M258.43M230.27M233.49M210.83M201.46M189.41M164.09M
Revenue Growth %-1.89%-32.73%-14.52%68.38%80.15%65.94%40.79%38.93%63.1%53.54%44.1%11.89%20.24%28.28%21.57%42.29%43.49%38.81%31.6%19.46%
Cost of Goods Sold0398.71M150.78M152.56M137.56M132.3M91.69M44.55M50.56M44.18M37.03M34.12M35.02M30.8M39.95M37.8M31.44M31.74M23.44M19.52M
COGS % of Revenue-90.02%37.75%24.96%18.47%20.09%19.63%12.27%12.23%11.13%11.16%13.06%13.81%11.92%17.35%16.19%14.91%15.76%12.38%11.89%
Gross Profit044.23M248.58M458.53M607.29M526.11M375.48M318.39M362.9M352.61M294.79M227.11M218.48M227.63M190.32M195.69M179.39M169.72M165.96M144.57M
Gross Margin %-9.98%62.25%75.04%81.53%79.91%80.37%87.73%87.77%88.87%88.84%86.94%86.19%88.08%82.65%83.81%85.09%84.24%87.62%88.11%
Gross Profit Growth %-100%-91.59%-33.8%44.02%67.34%49.21%27.37%40.19%66.1%54.9%54.89%16.06%21.79%34.12%14.67%35.36%43.99%38.28%28.74%16.57%
Operating Expenses262.91M455.81M351.97M342.96M907.68M364.43M353.29M319.09M328M327.98M315.63M360.63M356.57M334.46M321.67M406.82M266.27M275.53M200.42M312.15M
OpEx % of Revenue35.98%102.91%88.13%56.12%121.86%55.35%75.62%87.92%79.33%82.66%95.12%138.05%140.66%129.42%139.69%174.24%126.3%136.77%105.81%190.23%
Selling, General & Admin108.95M128.3M91.89M137.9M133.63M163.87M128.2M138.8M127M131.7M120.89M118.56M110.71M120.48M104.79M154.32M71.84M78.06M61.13M72.35M
SG&A % of Revenue14.91%28.97%23.01%22.57%17.94%24.89%27.44%38.24%30.72%33.19%36.43%45.39%43.67%46.62%45.51%66.09%34.07%38.74%32.27%44.09%
Research & Development153.96M325.34M218.89M204.39M773.45M199.95M224.48M179.69M200.4M195.52M194.3M241.89M245.68M213.8M216.71M252.33M194.25M197.3M139.12M239.62M
R&D % of Revenue21.07%73.45%54.81%33.45%103.84%30.37%48.05%49.51%48.47%49.28%58.56%92.59%96.91%82.73%94.11%108.07%92.14%97.93%73.45%146.03%
Other Operating Expenses01000K1000K667K601K601K602K601K601K763K439K179K178K179K178K179K178K179K178K179K
Operating Income358.43M-411.58M-103.39M115.58M-300.39M161.68M22.2M-701K34.91M24.63M-20.84M-133.52M-138.09M-106.83M-131.35M-211.13M-86.88M-105.81M-34.46M-167.57M
Operating Margin %49.05%-92.92%-25.89%18.91%-40.33%24.56%4.75%-0.19%8.44%6.21%-6.28%-51.11%-54.47%-41.34%-57.04%-90.43%-41.21%-52.52%-18.19%-102.12%
Operating Income Growth %219.32%-354.56%-565.8%16587.45%-960.58%556.57%206.5%99.48%125.28%123.05%84.13%36.76%-58.94%-0.96%-281.2%-25.99%42.79%38.02%74.86%-21.12%
EBITDA358.43M-406.33M-84.94M126.42M-290.41M172.14M32M8.02M43.65M36M-9.91M-122.73M-126.78M-96.28M-120.65M-201.24M-76.16M-95.67M-23.96M-159.13M
EBITDA Margin %49.05%-91.74%-21.27%20.69%-38.99%26.14%6.85%2.21%10.56%9.07%-2.99%-46.98%-50.01%-37.26%-52.4%-86.19%-36.12%-47.49%-12.65%-96.98%
EBITDA Growth %223.42%-336.05%-365.42%1476.66%-765.33%378.2%422.8%106.53%134.43%137.39%91.78%39.02%-66.46%-0.64%-403.49%-26.47%46.72%41.46%81.63%-20.66%
D&A (Non-Cash Add-back)05.25M18.45M10.84M9.98M10.46M9.81M8.72M8.74M11.37M10.93M10.79M11.3M10.55M10.7M9.89M10.72M10.14M10.49M8.45M
EBIT0-257.45M-186.48M158.87M-379.01M176.22M38.92M18.41M45.61M45.6M-27.95M-9.36M-506.39M-94.62M-241.68M-212.06M-88.35M-105.84M-31.91M-65.93M
Net Interest Income0816K816K1.91M7.92M10.22M13.41M14.01M15.73M17.39M17.59M15.98M12.99M2.44M-6.52M-13.62M-15.58M-15.95M-15.85M-15.78M
Interest Income08.38M8.38M7.14M12.43M14.7M18.33M18.84M19.9M22.63M22.82M21.2M19.32M9.13M8.21M2.41M215K95K148K52K
Interest Expense07.57M7.57M5.23M4.5M4.47M4.92M4.83M4.17M5.23M5.23M5.22M6.32M6.69M14.74M16.03M15.8M16.05M15.99M15.83M
Other Income/Expense-15.26M133.29M-90.66M38.06M-83.13M10.06M11.81M14.28M6.54M15.75M-12.33M118.93M-374.62M5.53M-125.06M-16.96M-17.27M-16.08M-13.45M85.81M
Pretax Income343.17M-278.3M-194.05M153.64M-383.52M171.74M34.01M13.58M41.45M40.37M-33.17M-14.59M-512.71M-101.31M-256.42M-228.09M-104.15M-121.89M-47.91M-81.76M
Pretax Margin %46.96%-62.83%-48.59%25.14%-51.49%26.08%7.28%3.74%10.02%10.17%-10%-5.58%-202.25%-39.2%-111.36%-97.69%-49.4%-60.5%-25.29%-49.83%
Income Tax12.21M4.55M-14.1M-43.25M63.99M12.69M395K7.12M5.33M-5.28M7.76M9.36M4.04M7.94M1.32M3.39M879K92K237K-354K
Effective Tax Rate %3.56%-1.64%7.27%-28.15%-16.69%7.39%1.16%52.42%12.86%-13.09%-23.4%-64.14%-0.79%-7.84%-0.51%-1.49%-0.84%-0.08%-0.49%0.43%
Net Income330.96M-282.85M-179.95M196.89M-447.51M159.05M33.61M6.46M36.12M45.66M-40.94M-23.94M-516.75M-109.24M-257.74M-231.48M-105.03M-121.98M-48.14M-81.41M
Net Margin %45.29%-63.86%-45.06%32.22%-60.08%24.16%7.19%1.78%8.74%11.51%-12.34%-9.16%-203.85%-42.27%-111.93%-99.14%-49.81%-60.55%-25.42%-49.61%
Net Income Growth %173.96%-277.84%-635.38%2947.86%-1338.98%248.37%182.1%126.98%106.99%141.79%84.12%89.66%-392.03%10.44%-435.35%-184.36%37.2%35.57%75.5%46.03%
Net Income (Continuing)330.96M-282.85M-179.95M196.89M-447.51M159.05M33.61M6.46M36.12M45.66M-40.94M-23.94M-516.75M-109.24M-257.74M-231.48M-105.03M-121.98M-48.14M-81.41M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)2.88-3.93-1.801.89-4.601.500.330.070.370.43-0.46-0.27-5.86-1.24-2.94-2.65-1.20-1.45-0.60-1.02
EPS Growth %162.61%-362%-645.45%2600%-1343.24%248.84%171.74%125.93%106.31%134.68%84.35%89.81%-388.33%14.48%-390%-159.8%42.86%39.83%76%47.15%
EPS (Basic)3.15-2.74-1.802.01-4.601.650.350.070.380.49-0.46-0.27-5.86-1.24-2.94-2.65-1.20-1.45-0.60-1.02
Diluted Shares Outstanding121.92M104.79M100.24M106.62M97.36M108.47M100.45M99.14M99.11M105.59M88.89M88.74M88.19M87.84M87.63M87.51M87.25M84.26M79.88M79.75M
Basic Shares Outstanding104.99M104.79M100.24M98M97.36M96.28M95.39M94.62M93.99M93.62M88.89M88.74M88.19M87.84M87.63M87.35M87.25M84.26M79.88M79.75M
Dividend Payout Ratio--------------------